XT
IGC icon

XTX Topco’s IGC Pharma IGC Stock Holding History

XTX Topco’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.3K Buy
50,648
+22,324
+79% +$6.2K ﹤0.01% 3635
2025
Q4 		$7.97K Sell
28,324
-5,679
-17% -$2.02K ﹤0.01% 3210
2025
Q3 		$14.2K Buy
34,003
+20,238
+147% +$7.7K ﹤0.01% 2386
2025
Q2 		$4.21K Sell
13,765
-18,318
-57% -$5.5K ﹤0.01% 2261
2025
Q1 		$9.14K Buy
+32,083
New +$10.1K ﹤0.01% 2260
2024
Q2 		– Sell
-29,272
Closed -$11.7K – 2138
2024
Q1 		$11.7K Buy
+29,272
New +$9.09K ﹤0.01% 1665

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

XTX Topco's IGC Position: Q1 2026 in Review

XTX Topco increased its IGC Pharma (IGC) stake by 79% in Q1 2026, buying an estimated $6.2K and bringing the position to 50,648 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3635.

XTX Topco first reported a position in IGC in Q1 2024 and has held it in 6 quarters since. The position peaked at $14.2K in Q3 2025. 35 funds tracked by Wall St. Rank hold IGC as of Q1 2026.

  • XTX Topco held 50,648 shares of IGC Pharma worth $13.3K as of Q1 2026.
  • XTX Topco bought 22,324 IGC Pharma shares in Q1 2026, an estimated $6.2K.
  • IGC Pharma made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3635 holding.
  • XTX Topco first reported a position in IGC Pharma in Q1 2024 and has held it in 6 quarters since.
  • XTX Topco's IGC Pharma position peaked at $14.2K in Q3 2025.
  • 35 funds tracked by Wall St. Rank held IGC Pharma as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.